<html>  <head> <title>Publications 1996</title> <meta name="GENERATOR" content="Microsoft FrontPage 4.0">   <meta name="Microsoft Theme" content="copie-de-aquarelle 111, default"> <meta name="Microsoft Border" content="tb, default"> </head>  <body background="../_themes/copie-de-aquarelle/sumtextb.jpg" bgcolor="#FFFFCC" text="#000066" link="#660099" vlink="#993366" alink="#6666CC"><!--msnavigation--><table border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td><!--mstheme--><font face="Verdana, Arial, Helvetica">  <p align="center"><font size="6"><strong><img src="_derived/art1996.htm_cmp_copie-de-aquarelle110_bnr.gif" width="600" height="60" border="0" alt="Publications 1996"></strong></font><br> <script language="JavaScript"><!-- MSFPhover =    (((navigator.appName == "Netscape") &&    (parseInt(navigator.appVersion) >= 3 )) ||    ((navigator.appName == "Microsoft Internet Explorer") &&    (parseInt(navigator.appVersion) >= 4 )));  function MSFPpreload(img)  {   var a=new Image(); a.src=img; return a;  } // --></script><script language="JavaScript"><!-- if(MSFPhover) { MSFPnav1n=MSFPpreload("../_derived/home_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav1h=MSFPpreload("../_derived/home_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="../" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav1'].src=MSFPnav1h.src" onmouseout="if(MSFPhover) document['MSFPnav1'].src=MSFPnav1n.src"><img src="../_derived/home_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Accueil" align="middle" name="MSFPnav1"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav2n=MSFPpreload("../_derived/up_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav2h=MSFPpreload("../_derived/up_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="publicat.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav2'].src=MSFPnav2h.src" onmouseout="if(MSFPhover) document['MSFPnav2'].src=MSFPnav2n.src"><img src="../_derived/up_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Retour" align="middle" name="MSFPnav2"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav3n=MSFPpreload("_derived/art1994.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav3h=MSFPpreload("_derived/art1994.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art1994.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav3'].src=MSFPnav3h.src" onmouseout="if(MSFPhover) document['MSFPnav3'].src=MSFPnav3n.src"><img src="_derived/art1994.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 1994" align="middle" name="MSFPnav3"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav4n=MSFPpreload("_derived/art1995.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav4h=MSFPpreload("_derived/art1995.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art1995.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav4'].src=MSFPnav4h.src" onmouseout="if(MSFPhover) document['MSFPnav4'].src=MSFPnav4n.src"><img src="_derived/art1995.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 1995" align="middle" name="MSFPnav4"></a> <img src="_derived/art1996.htm_cmp_copie-de-aquarelle110_hbtn_p.gif" width="140" height="40" border="0" alt="Publications 1996" align="middle"> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav5n=MSFPpreload("_derived/art1997.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav5h=MSFPpreload("_derived/art1997.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art1997.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav5'].src=MSFPnav5h.src" onmouseout="if(MSFPhover) document['MSFPnav5'].src=MSFPnav5n.src"><img src="_derived/art1997.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 1997" align="middle" name="MSFPnav5"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav6n=MSFPpreload("_derived/art1998.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav6h=MSFPpreload("_derived/art1998.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art1998.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav6'].src=MSFPnav6h.src" onmouseout="if(MSFPhover) document['MSFPnav6'].src=MSFPnav6n.src"><img src="_derived/art1998.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 1998" align="middle" name="MSFPnav6"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav7n=MSFPpreload("_derived/art1999.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav7h=MSFPpreload("_derived/art1999.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art1999.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav7'].src=MSFPnav7h.src" onmouseout="if(MSFPhover) document['MSFPnav7'].src=MSFPnav7n.src"><img src="_derived/art1999.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 1999" align="middle" name="MSFPnav7"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav8n=MSFPpreload("_derived/art2000.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav8h=MSFPpreload("_derived/art2000.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art2000.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav8'].src=MSFPnav8h.src" onmouseout="if(MSFPhover) document['MSFPnav8'].src=MSFPnav8n.src"><img src="_derived/art2000.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 2000" align="middle" name="MSFPnav8"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav9n=MSFPpreload("_derived/art2001.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav9h=MSFPpreload("_derived/art2001.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art2001.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav9'].src=MSFPnav9h.src" onmouseout="if(MSFPhover) document['MSFPnav9'].src=MSFPnav9n.src"><img src="_derived/art2001.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 2001" align="middle" name="MSFPnav9"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav10n=MSFPpreload("_derived/art2002.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav10h=MSFPpreload("_derived/art2002.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="art2002.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav10'].src=MSFPnav10h.src" onmouseout="if(MSFPhover) document['MSFPnav10'].src=MSFPnav10n.src"><img src="_derived/art2002.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Publications 2002" align="middle" name="MSFPnav10"></a> <script language="JavaScript"><!-- if(MSFPhover) { MSFPnav11n=MSFPpreload("_derived/ouvrages.htm_cmp_copie-de-aquarelle110_hbtn.gif"); MSFPnav11h=MSFPpreload("_derived/ouvrages.htm_cmp_copie-de-aquarelle110_hbtn_a.gif"); } // --></script><a href="ouvrages.htm" language="JavaScript" onmouseover="if(MSFPhover) document['MSFPnav11'].src=MSFPnav11h.src" onmouseout="if(MSFPhover) document['MSFPnav11'].src=MSFPnav11n.src"><img src="_derived/ouvrages.htm_cmp_copie-de-aquarelle110_hbtn.gif" width="140" height="40" border="0" alt="Ouvrages et chapitres" align="middle" name="MSFPnav11"></a></p>  <p align="center">&nbsp;</p>  <!--mstheme--></font></td></tr><!--msnavigation--></table><!--msnavigation--><table border="0" cellpadding="0" cellspacing="0" width="100%"><tr><!--msnavigation--><td valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"> <font FACE="Verdana"><div align="center"><center>  <!--mstheme--></font><table CELLSPACING="0" BORDER="0" CELLPADDING="4" WIDTH="625">   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2"><a name="debut"></a></font><font SIZE="2">96-01</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Abina MA, Lee MG, Descamps V, Cordier L, Lopez M,     Perricaudet M, Haddada H. LacZ gene transfer into tumor cells abrogates tumorigenicity and     protects mice against the development of further tumors. Gene Ther. 1996;3:212-216.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-02</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Bartoleyns J, Romet Lemonne JL, Chokri M, Lopez M. Immune     therapy with macrophages: present status and critical requirements for implementation.     Immunobiology. 1996;195:550-562.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-03</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Begue P, Bernuau J, Courouc AM, Desenclos JC, Cabo B,     Goudeau A, Jullien AM, Tirard V. La prvention de la transmission du virus de l'hpatite     A en situation pidmique. BEH. 1996;219-223.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-04</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Bolle PY, Garnerin P, Hergon E, Rouger P, Valleron AJ.     Assurance de la qualit et prvention des incidents immuno-hmolytiques en transfusion     sanguine. Transfus Clin Biol. 1996;3:27-34.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-05</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Boukerche H, Ruchaud Sparagano MH, Rouen C, Brochier J,     Kaplan C, McGregor JL. A&nbsp;monoclonal antibody directed against a granule membrane     glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet     aggregation. Br J Haematol. 1996;92:442-451.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-06</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Brossard Y, Dangu C, Patereau C, Goossens D. Functional     (ADCC) study of 54 IgG Mab anti-RhD. Transfus Clin Biol. 1996;3:459-463.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-07</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Carr N, Meyer L, Boufassa F, Deveau C, Persoz A, Rouzioux     C, Vilde JL, SEROCO Study Group. High risk of HIV disease progression after infection     through a sexual partner with AIDS. AIDS. 1996;10:77-80.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-08</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Cartron J, Fior R, Bou F, Tertian G, Gane P, Cartron JP.     Non Hodgkin's lymphoma presenting as neutropenia related to an IgM monoclonal anti-i     antibody. Hematol Cell Ther. 1996;38:225-230.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-09</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Cartron JP, Rouillac C, Le Van Kim C, Mouro I, Colin Y.     Tentative model for the mapping of D epitopes on the RhD polypeptide. Transfus Clin Biol.     1996;3:497-503.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-10</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Cartron JP. Rh DNA - Coordinator's report. Transfus Clin     Biol. 1996;3:491-495.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-11</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Cartron JP. Vers une approche molculaire de la structure,     du polymorphisme et de la fonction des groupes sanguins. Transfus Clin Biol.     1996;3:181-210.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-12</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Chrif Zahar B, Raynal V, Cartron JP. Lack of RHCE-encoded     proteins in the D--phenotype may result from homologous recombination between the two <i>RH</i>     genes. Blood. 1996;88:1518-1520.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-13</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Chrif Zahar B, Raynal V, Gane P, Mattei MG, Bailly P,     Gibbs B, Colin Y, Cartron JP. Candidate gene acting as a suppressor of the RH locus in     most cases of Rh-deficiency. Nat Genet. 1996;12:168-173.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-14</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Chrtien S, Gisselbrecht S. Comment cloner un rcepteur     pour une nouvelle cytokine. Hmatologie. 1996;2:321-328.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-15</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Chrtien S, Varlet P, Verdier F, Gobert S, Cartron JP,     Gisselbrecht S, Mayeux P, Lacombe&nbsp;C. Erythropoietin-induced erythroid differentiation     of the human erythroleukemia cell line TF</font><font SIZE="1">&#150;</font><font SIZE="2">1     correlates with impaired STAT5 activation. EMBO J. 1996;15:4174-4181.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-16</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Cochet S, Pesliakas H, Kroviarski Y, Cartron JP, Bertrand     O. Chromatography of bovine lactoserum on an immobilized metallized dye Rubine R/K 5BL:     modulation of selectivity by metal exchange and application to purification of milk     immunoglobulins. J Chromatogr&nbsp;A. 1996;725:237-247.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-17</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Courouc AM, Pillonel J, Groupes de travail     &quot;Rtrovirus&quot; et &quot;Hpatites Virales&quot; de la SFTS. Estimation du risque     de transmission des virus des hpatites B et C et des rtrovirus humains par transfusion     de drivs sanguins labiles. Transfus Clin Biol. 1996;3:13-18.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-18</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Courouc AM, Pillonel J, Groupes de travail     &quot;Rtrovirus&quot; et &quot;Hpatites Virales&quot; de la SFTS. Estimation du risque     de transmission des virus des hpatites B et C et des rtrovirus par transfusion de     drivs sanguins labiles. BEH. 1996;54-55.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-19</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Courouc AM, Pillonel J, Groupes de travail     &quot;Rtrovirus&quot; et &quot;Hpatites Virales&quot; de la SFTS.     Transfusion-transmitted viral infections. N Engl J Med. 1996;335:1609-1610.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-20</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Daniels GL, Anstee DJ, Cartron JP, Dahr W, Henry S, Issitt     PD, Jorgensen J, Judd WJ, Kornstad L, Levene C, Lomas Francis C, Lubenko A, Mallory D,     Moulds JM, Moulds JJ, Okubo Y, Overbeeke M, Reid ME, Rouger P, Seidl S, Sistonen S, Wendel     S, Zelinski T. Terminology for red cell surface antigens. Makuhari Report. Vox Sang.     1996;71:246-248.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-21</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">De Groote D, Gevaert Y, Lopez M, Gathy R, Marchal F, Detroz     B, Jacquet N, Geenen V. Ex&nbsp;vivo cytokine production by whole blood cells from cancer     patients. Cancer Detect Prev. 1996;20:207-213.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-22</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Desaymard C, Kaplan C, Fournier C, Manigne P, Hayem F, Kahn     MF, Prieur AM. Major histocompatibility complex markers and disease heterogeneity in one     hundred eight patients with systemic onset juvenile chronic arthritis. Rev Rhum Engl Ed.     1996;63:9-16.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-23</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Devignes J, Le Pennec PY, Gien D, Mannessier L, Rouger P,     Groupe de travail &quot;Immunohmatologie&quot; de la SFTS. Test direct      l'antiglobuline et lution directe : bilan d'un contrle de qualit d'tablissements     de transfusion sanguine. Transfus Clin Biol. 1996;3:241-246.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-24</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Dromigny A, Triadou P, Lesavre P, Morel Kopp MC, Kaplan C.     Lack of platelet response to collagen associated with autoantibodies against glycoprotein     (GP) Ia/IIa and Ib/IX leading to the discovery of SLE. Hematol Cell Ther. 1996;38:355-357.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-25</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Durand Zaleski I, Schlegel N, Blum Boisgard C, Uzan S,     Dreyfus M, Kaplan C, Immune Thrombocytopenia Working Group. Screening primiparous women     and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of     effectiveness and costs. Am J Perinatol. 1996;13:423-431.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-26</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Eymard JC, Lopez M, Cattan A, Bouche O, Adjizian JC,     Bernard J. Phase I/II trial of autologous activated macrophages in advanced colorectal     cancer. Eur J Cancer. 1996;32A:1905-1911.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-27</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Flandre P, Boufassa F, Grard L, Carr N, Persoz A, Meyer     L, SEROCO Study Group. The use of auxiliary events to improve the analysis of survival for     HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO).     J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:174-181.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-28</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Gobert S, Chrtien S, Gouilleux F, Muller O, Pallard C,     Dusanter Fourt I, Groner B, Lacombe C, Gisselbrecht S, Mayeux P. Identification of     tyrosine residues within the intracellular domain of the erythropoietin receptor crucial     for STAT5 activation. EMBO J. 1996;15:2434-2441.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-29</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Hasnaoui M, Blanchard D, Willem C, Loirat MJ, Lambin P.     Production and properties of monoclonal antibodies against human IgG isotypes. Hybridoma.     1996;15:351-358.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-30</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Hebbar M, Kaplan C, Caulier MT, Wattel E, Morel P,     Wetterwald M, Bauters F, Fenaux P. Low incidence of specific anti-platelet antibodies     detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of     correlation between platelet autoantibodies, platelet lifespan and response to danazol     therapy. Br J Haematol. 1996;94:112-115.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-31</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Hergon E, Guez P, Lopez R, Cabaud JJ, Garnerin P, Rouger P.     Amlioration de la scurit transfusionnelle dans un tablissement de sant par le     dveloppement d'une dmarche qualit. Transfus Clin Biol. 1996;3:305-314.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-32</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Hergon E. Principes gnraux de la qualit,     spcificits dans le milieu hospitalier, tat des lieux des dmarches qualit dans le     secteur hospitalier. Ergonomie et Qualit : Sant. 1996;1:5-10.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-33</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Hermand P, Le Pennec PY, Rouger P, Cartron JP, Bailly P.     Characterization of the gene encoding the human LW blood group protein in LW+ and LW-     phenotypes. Blood. 1996;87:2962-2967.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-34</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Ibrahim Granet O, Bertrand O. Separation of proteases, old     and new approaches. J Chromatogr B. 1996;684:239-263.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-35</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Kaplan C, Forestier F, Daffos F, Tchernia G, Waters A.     Management of fetal and neonatal alloimmune thrombocytopenia. Transfus Med Rev.     1996;10:233-240.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-36</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Kaplan C, Morel Kopp MC, Kieny MP, Kolbe H, Salmon D,     Sicard D, Pialoux G, Meignier B, Excler JL, Plotkin S. Antiplatelet antibodies during the     course of HIV-preventive vaccine trial. AIDS. 1996;10:447-449.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-37</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Kroll H, Kiefel V, Giers G, Kaplan C, Murphy M, Waters A,     Mueller Eckhardt C. [Prenatal management of fetuses with alloimmune thrombocytopenia]     Pranatale Betreuung von Feten mit Alloimmunthrombozytopenie. Beitr Infusionsther     Transfusionsmed. 1996;33:150-155.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-38</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Laporte JP, Gorin NC, Rubinstein P, Lesage S, Portnoi MF,     Barbu V, Lopez M, Douay L, Najman A. Cord-blood transplantation from an unrelated donor in     an adult with chronic myelogenous leukemia. N Engl J Med. 1996;335:167-170.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-39</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Le Pennec PY, Gane P, Noizat Pirenne F, Braddock D, Cartron     JP, Rouger P. Flow cytometric evaluation of non anti-RH1(D) monoclonal Rh antibodies.     Transfus Clin Biol. 1996;3:433-435.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-40</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Le Pennec PY, Noizat Pirenne F, Klein MT, Fraval D, Lascaux     JM, Rouger P. Serological studies of monoclonal RH1(D) antibodies with RH1(D) variants.     Transfus Clin Biol. 1996;3:401-404.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-41</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Le Pennec PY, Tissier AM, Mannessier L, Agulles O, Babinet     J, Bidet ML, Bombail Girard D, Cabaud JJ, Cartron J, Chiaroni J, Desaint C, Krause C, Lamy     B, Meyer F, Mortelecque R, Nafissi S, Rasongles P, Schweitzer B, Rouger P. Les accidents     immuno-hmolytiques transfusionnels. III. Etude de 61 cas. Transfus Clin Biol.     1996;3:157-165.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-42</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Le Pennec PY, Tissier AM, Noizat Pirenne F, Rouger P. Les     accidents immuno-hmolytiques transfusionnels. II. Bases physiopathologiques et     diagnostic. Transfus Clin Biol. 1996;3:149-155.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-43</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Le Van Kim C, Piller V, Cartron JP, Colin Y. Glycophorins C     and D are generated by the use of alternative translation initiation sites. Blood.     1996;88:2364-2365.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-44</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lefrre JJ, Elghouzzi MH, Salptrier J, Duc A, Dupuy     Montbrun MC. Interviews of individuals diagnosed as anti-HIV positive through the     screening of blood donations in the Paris area between 1991 and 1994: reflections for the     selection of blood donors. Transfusion. 1996;36:124-127.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-45</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lefrre JJ, Loiseau P, Martinot Peignoux M, Mariotti M,     Ravera N, Thauvin M, Marcellin P, Janot C. Infection by hepatitis C virus through     contaminated intravenous immune globulin: results of a prospective national inquiry in     France. Transfusion. 1996;36:394-397.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-46</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lefrre JJ, Loiseau P, Pawlotsky JM. Le virus G/GBV-C : de     l'hpatologie  l'hmatologie. Hmatologie. 1996;2:537-544.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-47</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lefrre JJ, Loiseau P. Le risque de transmission du virus     de l'hpatite C par les immunoglobulines intraveineuses. Hmatologie. 1996;2:141-145.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-48</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lefrre JJ, Mariotti M, Lerable J, Thauvin M, Girot R.     Long-term persistence of hepatitis G virus in immunocompetent patients. Lancet.     1996;348:1174-1175.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-49</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lefrre JJ, Meyohas MC, Mariotti M, Meynard JL, Thauvin M,     Frottier J. Detection of eighth human herpesvirus (HHV-8) DNA sequences before the     appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects     with a known date of HIV seroconversion. J Infect Dis. 1996;174:283-287.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-50</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lefrre JJ, Roudot Thoraval F, Vittecoq D, Heshmati F,     Audat F, Lerable J, Reed D, Petit&nbsp;JC, Burghoffer B, Morand Joubert L. Quantitation of     passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients     transfused with a plasma that is rich in HIV antibodies. Transfusion. 1996;36:734-738.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-51</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Lopez M, Bony V, Vincent M, Chokri M, Martinache C, Abina     MA, Bernard J. Tumoricidal potentiality of human macrophages grown in vitro from blood     monocytes. J Exp Ther Oncol. 1996;1:143-154.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-52</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Maniez Montreuil M, Dupressoir MV, Courouc AM, Groupe de     travail &quot;Hpatites Virales&quot; de la SFTS. Rvaluation de la sensibilit des     trousses de dpistage de l'antigne HBs (Ag&nbsp;HBs). Spectra Biol. 1996;15:31-39.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-53</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Mansour I, Klaym S, Naman R, Loiselet J, Hall L, Kaplan     C. Polymorphisme du phnotype HLA dans la population libanaise. Transfus Clin Biol.     1996;3:289-295.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-54</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Martial S, Olivs B, Abrami L, Couriaud C, Bailly P, You     G, Hediger MA, Cartron JP, Ripoche P, Rousselet G. Functional differentiation of the human     red blood cell and kidney urea transporters. Am J Physiol. 1996;271:F1264-F1268.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-55</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Morel Kopp MC, Daviet L, McGregor JL, Kaplan C. Drawbacks     of the MAIPA technique in characterising human antiplatelet antibodies. Blood Coagul     Fibrinolysis. 1996;7:144-146.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-56</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Mouillot L, Courouc AM, Simon F, Mauclre P, Maisonneuve     P, Janot C. Rvaluation de la sensibilit de ractifs de dpistage des anticorps     anti-VIH vis--vis du sous-type O. Spectra Biol. 1996;15:47-49.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-57</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Mouro I, Colin Y, Gane P, Collec E, Zelinski T, Cartron JP,     Le Van Kim C. Molecular analysis of blood group Rh transcripts from a rGr variant. Br J     Haematol. 1996;93:472-474.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-58</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Noizat Pirenne F, Mouro I, Gane P, Aubin JT, Rouger P, Le     Pennec PY, Colin Y, Cartron JP. Molecular analysis of selected Rh variants. Transfus Clin     Biol. 1996;3:517-519.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-59</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Olivs B, Martial S, Mattei MG, Matassi G, Rousselet G,     Ripoche P, Cartron JP, Bailly P. Molecular characterization of a new urea transporter in     the human kidney. FEBS Lett. 1996;386:156-160.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-60</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Pillonel J, Courouc AM, Elghouzzi MH, Piquet Y, Lemaire     JM. Seroconversions to HTLV in blood donors. Vox Sang. 1996;70:47.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-61</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Pillonel J, Saura C, Courouc AM. Dpistage des marqueurs     d'une infection par le VIH, l'HTLV et les virus des hpatites B et C chez les donneurs de     sang en France. BEH. 1996;9-11.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-62</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Promeneur D, Rousselet G, Bankir L, Bailly P, Cartron JP,     Ripoche P, Trinh Trang Tan MM. Evidence for distinct vascular and tubular urea     transporters in the rat kidney. J Am Soc Nephrol. 1996;7:852-860.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-63</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Rahuel C, Le Van Kim C, Mattei MG, Cartron JP, Colin Y. A     unique gene encodes spliceoforms of the B-cell adhesion molecule cell surface glycoprotein     of epithelial cancer and of the Lutheran blood group glycoprotein. Blood.     1996;88:1865-1872.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-64</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Rouger P, Hergon E. Les produits thrapeutiques d'origine     humaine. Transfus Clin Biol. 1996;3:87-88.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-65</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Rouger P, Van Huffel V. Polymorphisme de I'ADN et     exclusions de paternit : analyse de 543 cas de recherche de filiation. Transfus Clin     Biol. 1996;3:273-278.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-66</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Rouger P. Les accidents immuno-hmolytiques     transfusionnels. I. Gnralits. Transfus Clin Biol. 1996;3:145-147.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-67</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Rouillac C, Gane P, Cartron J, Le Pennec PY, Cartron JP,     Colin Y. Molecular basis of the altered antigenic expression of RhD in weak D (Du) and     RhC/e in RN phenotypes. Blood. 1996;87:4853-4861.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-68</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Rousselet G, Ripoche P, Bailly P. Tandem sequence repeats     in urea transporters: identification of an urea transporter signature sequence. Am J     Physiol. 1996;270:F554-F555.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-69</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Schuller E, Lambin P, Deloche G. Long-term treatment of     multiple sclerosis with IgG immunotherapy. Pathol Biol Paris. 1996;44:710-715.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-70</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Semana G, Zazoun T, Alizadeh M, Morel Kopp MC, Genetet B,     Kaplan C. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization. Role     of HLA class II and TAP genes. Hum Immunol. 1996;46:114-119.</font><!--mstheme--></font></td>   </tr>   <tr>     <td WIDTH="10%" valign="top"><!--mstheme--><font face="Verdana, Arial, Helvetica"><h4><!--mstheme--><font color="#006666"><font SIZE="2">96-71</font><!--mstheme--></font></h4>     <!--mstheme--></font></td>     <td WIDTH="90%"><!--mstheme--><font face="Verdana, Arial, Helvetica"><font SIZE="2">Tissier AM, Le Pennec PY, Hergon E, Rouger P. Les accidents     immuno-hmolytiques transfusionnels. IV. Analyse, risques et prvention. Transfus Clin     Biol. 1996;3:167-180.</font><!--mstheme--></font></td>   </tr> </table><!--mstheme--><font face="Verdana, Arial, Helvetica"> </center></div>  <blockquote>   <blockquote>     <h3 ALIGN="CENTER"><!--mstheme--><font color="#990000"><b><a href="art1996.htm#debut"><img src="../images/flechaut.gif" alt="flechaut.gif (883 octets)" border="0" WIDTH="17" HEIGHT="16"></a></b><!--mstheme--></font></h3>   </blockquote> </blockquote>  <p>&nbsp; </font> <!--mstheme--></font><!--msnavigation--></td></tr><!--msnavigation--></table><!--msnavigation--><table border="0" cellpadding="0" cellspacing="0" width="100%"><tr><td><!--mstheme--><font face="Verdana, Arial, Helvetica">  <!--msthemeseparator--><p align="center"><img src="../_themes/copie-de-aquarelle/sumhorsa.gif" width="600" height="10"></p>  <p align="center"><nobr>[&nbsp;<a href="../">Accueil</a>&nbsp;]</nobr> <nobr>[&nbsp;<a href="publicat.htm">Retour</a>&nbsp;]</nobr> </p>  <!--mstheme--></font></td></tr><!--msnavigation--></table></body> </html> 
